Evidence map›Paper›PMID 38133618›Full record

Trial reportAmerican journal of physiology. Heart and circulatory physiology2024

Electronic hookah (waterpipe) vaping reduces vascular endothelial function: the role of nicotine.

Mary Rezk-Hanna, Matthew J Rossman, Katelyn Ludwig, Primadya Sakti, Chiao-Wei Cheng, Mary-Lynn Brecht, Neal L Benowitz, Douglas R Seals

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of physiology. Heart and circulatory physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Chemical Constituents and Particle Size Distribution of Mainstream Emission From Electronic Waterpipe.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  6. Promoting Resiliency to Stress in the Vascular Endothelium.Basic & clinical pharmacology & toxicology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mary Rezk-HannaSchool of Nursing, University of California, Los Angeles, Los Angeles, California, United States.
Matthew J RossmanDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.ORCID 0000-0001-9381-2590
Katelyn LudwigDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.
Primadya SaktiSchool of Nursing, University of California, Los Angeles, Los Angeles, California, United States.
Chiao-Wei ChengSchool of Nursing, University of California, Los Angeles, Los Angeles, California, United States.
Mary-Lynn BrechtSchool of Nursing, University of California, Los Angeles, Los Angeles, California, United States.
Neal L BenowitzClinical Pharmacology Research Program, Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California, United States.
Douglas R SealsDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.ORCID 0000-0002-2391-9824
University of California, Los Angeles · USUniversity of Colorado Boulder · USUniversity of California, San Francisco · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Research Support CoreP30DA012393 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JACOB, PEYTON · 1999 to 2024
$17.1M
Nevada Utilization of NV WebIZ (SIIS) to Conduct AFIX VisitsH23IP001013 · IP · HEALTH AND HUMAN SERVICES, NEVADA DEPARTMENT OF · PI WHITLEY, RICHARD · 2015 to 2015
$450k
HHS | National Institutes of Health (NIH) grant P30 DA12393HHS | National Institutes of Health (NIH) UL1TR001881NCATS NIH HHS UL1 TR001881NCIRD CDC HHS H23 IP001013NIDA NIH HHS P30 DA012393Tobacco-Related Disease Research Program (TRDRP) T30IP1013
6 · The paper itself

Abstract

Vaping has risen substantially in recent years, particularly among young adults. Electronic (e-) hookahs are a newer category of vaping devices touted as safer tobacco alternatives. Although e-hookah vaping acutely reduces endothelial function, the role of nicotine and the mechanisms by which it may impair endothelial function remain understudied. In a randomized crossover study, we investigated the acute effects of vaping e-hookah, with and without nicotine, as compared with sham on endothelial function assessed by brachial artery flow-mediated dilation (FMD), among 18 overtly healthy young adults. To determine the role of changes in circulating factors in plasma on endothelial cell function, human umbilical vein endothelial cells (HUVECs) were cultured with participants' plasma, and acetylcholine-stimulated nitric oxide (NO) production and basal reactive oxygen species (ROS) bioactivity were assessed. Plasma nicotine was measured before and after the sessions. E-hookah vaping with nicotine, which acutely increased heart rate (HR) by 8 ± 3 beats/min and mean arterial pressure (MAP) by 7 ± 2 mmHg (means ± SE;

Indexed as

Electronic Nicotine Delivery SystemsSmoking Water PipesVapingWater Pipe SmokingCross-Over StudiesEndothelial CellsHumansNicotineReactive Oxygen SpeciesYoung AdultNicotineReactive Oxygen Specieselectronic hookahendothelial dysfunctionnicotinenitric oxideoxidative stress

Identifiers

PMID38133618
PMCPMC11219048
OpenAlexW4390114966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.